Cas no 151767-02-1 (Montelukast Sodium)
Montelukast Sodium Chemical and Physical Properties
Names and Identifiers
-
- Montelukast Sodium
- 2-[1-[[1-[3-[2-[(7-chloro-2-quinolyl)]vinyl]phenyl]-3-[2-(1-hydroxy-1-methyl-ethyl)phenyl]-propyl]sulfanylmethyl]cyclopropyl]acetic acid sodium salt
- singulair
- mk-476
- Montelukast Sodium Hydrate
- Montelukast (sodium salt)
- Montelukast Sodium S
- Montelukast Sodium Salt
- Sodium (R,E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)thio)methyl)cyclopropyl)acetate
- sodium (R,S)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)thio)methyl)cyclopropyl)acetate
- sodium,2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate
- MK-0476
- MK-476-d6
- MONTELUKAST NA
- montelucast-d6
- MK-476, Singulair
- Motelukast SodiuM
- MONTELUKST SODIUM
- J-522711
- sodium (R,E)-2-(1-((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propylthio)methyl)cyclopropyl)acetate
- Tox21_112197_1
- Montelukast (as sodium)
- HMS2051F18
- AKOS015833416
- sodium;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate
- Montelukast sodium (JP17/USP)
- Sodium 1-((((R)-m -((E)-2-(7-chloro-2-quinolyl)vinyl)-alpha-(o-(1-hydroxy-1-methylethyl)phenethyl)benzyl)thio)methyl)cyclopropaneacetate
- MK 476
- SCHEMBL9414
- NC00299
- Montelukast sodium [USAN]
- HMS3885D11
- AKOS015994699
- SW197679-2
- CAS-151767-02-1
- MONTELUKAST MONOSODIUM SALT [MI]
- NCGC00164568-01
- DTXSID8046450
- BCP9000959
- sodium(R,E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)thio)methyl)cyclopropyl)acetate
- NCGC00164568-04
- M2340
- MONTELUKAST SODIUM [WHO-DD]
- MONTELUKAST SODIUM (EP MONOGRAPH)
- EN300-1608156
- Cyclopropaneacetic acid, 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-, sodium salt, (R-(E))-
- Singulair (TN)
- MLS001424198
- MONTELUKAST SODIUM [USP MONOGRAPH]
- Montelukast (sodium)
- MONTELUKAST SODIUM (MART.)
- MONTELUKAST SODIUM [VANDF]
- CS-0548
- Tox21_112197
- sodium 2-(1-((((R)-1-(3-((E)-2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)sulfanyl)methyl)cyclopropyl)acetate
- Lukasm
- MONTELUKAST SODIUM [JAN]
- 151767-02-1 (sodium)
- L-706631
- NSC-759107
- AKOS032949734
- 151767-02-1
- s4211
- NS00076434
- sodium 2-[1-({[(1R)-1-{3-[(1E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanyl}methyl)cyclopropyl]acetate
- BM164606
- NSC 759107
- EN300-123055
- MONTELUKAST SODIUM (USP-RS)
- MONTELUKAST SODIUM (USP MONOGRAPH)
- MK0476
- J-008841
- MONTELUKAST SODIUM [ORANGE BOOK]
- LBFBRXGCXUHRJY-HKHDRNBDSA-M
- MONTELUKAST SODIUM [USP-RS]
- Cyclopropaneacetic acid, 1-((((1R)-1-(3-((1E)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-, monosodium salt
- CHEBI:6993
- D00529
- SMR000469188
- MLS001304727
- 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid sodium salt
- MONTELUKAST SODIUM [EP MONOGRAPH]
- 2-[1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]thio]methyl]cyclopropyl]acetate; sodium
- CCG-101049
- HMS2235H19
- AM62787
- Kokast
- MK 0476
- HY-13315
- Q27107384
- sodium 2-[1-({[(1R)-1-{3-[2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanyl}methyl)cyclopropyl]acetate
- Montelukast monosodium salt
- KS-1087
- MONTELUKAST SODIUM [MART.]
- MFCD00931431
- sodium {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetate
- Montelukast sodium- Bio-X
- CPD000469188
- U1O3J18SFL
- DTXCID6026450
- Kipres
- Z2568666690
- sodium 1-[[[(1R)-1-[3-[(1E)-2-(7-chloroquinoline-2-yl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetate
- SODIUM 1-((((R)-M-((E)-2-(7-CHLORO-2-QUINOLYL)VINYL)-.ALPHA.-(O-(1-HYDROXY-1-METHYLETHYL)PHENETHYL)BENZYL)THIO)METHYL)CYCLOPROPANEACETATE
- CHEMBL1200681
- SCHEMBL9415
- Montair
- 1-((((1R)-1-(3-((1E)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid monosodium salt
- Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)
- UNII-U1O3J18SFL
- Sodium 1-((((R)-m-((E)-2-(7-chloro-2-quinolyl)vinyl)-alpha-(o-(1-hydroxy-1-methylethyl)phenethyl)benzyl)thio)methyl)cyclopropaneacetate
- Singular
- Montelukast for peak identification
- Montelukast Sodium?
- Montelukast sodium (JP18/USP)
-
- MDL: MFCD00931431
- Inchi: 1S/C35H36ClNO3S.Na/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39);/q;+1/p-1/b15-10+;/t32-;/m1./s1
- InChI Key: LBFBRXGCXUHRJY-HKHDRNBDSA-M
- SMILES: ClC1C=CC2C=CC(/C=C/C3=CC=CC(=C3)[C@@H](CCC3C=CC=CC=3C(C)(C)O)SCC3(CC(=O)[O-])CC3)=NC=2C=1.[Na+]
Computed Properties
- Exact Mass: 607.19200
- Monoisotopic Mass: 607.192
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 42
- Rotatable Bond Count: 12
- Complexity: 898
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 98.6A^2
Experimental Properties
- Melting Point: 84-90°C
- Boiling Point: 750.5°Cat760mmHg
- Flash Point: 407.7°C
- Solubility: DMSO: ≥8mg/mL at 60°C
- PSA: 98.55000
- LogP: 7.61330
- Merck: 6258
- Specific Rotation: +95.0° - +105.0° (c=1, MeOH)
- Solubility: DMSO: ≥8mg/mL at 60°C
Montelukast Sodium Security Information
-
Symbol:
- Signal Word:Danger
- Hazard Statement: H318-H361fd
- Warning Statement: P280-P305+P351+P338+P310
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Hazard Category Code: 63-41-62
- Safety Instruction: 26
- RTECS:GZ0698000
-
Hazardous Material Identification:
- Storage Condition:Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
Montelukast Sodium Customs Data
- HS CODE:2933499090
- Customs Data:
China Customs Code:
2933499090Overview:
2933499090. Other compounds containing quinoline or isoquinoline ring system [but not further fused]. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Montelukast Sodium Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | PHR1603-1G |
Montelukast Sodium |
151767-02-1 | 1g |
¥2049.88 | 2024-12-21 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | Y0001435 |
151767-02-1 | ¥1556.7 | 2023-01-13 | ||||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | Y0001434 |
Montelukast Sodium |
151767-02-1 | European Pharmacopoeia (EP) Reference Standard | ¥2654.27 | 2022-02-23 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 1446859-50MG |
Montelukast Sodium |
151767-02-1 | 50mg |
¥3302.56 | 2024-12-26 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | M849386-5g |
Montelukast Sodium Salt |
151767-02-1 | 98%,LC&T | 5g |
¥1,269.00 | 2022-09-01 | |
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | M2340-1G |
Montelukast Sodium |
151767-02-1 | >98.0%(T)(HPLC) | 1g |
¥310.00 | 2024-04-17 | |
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | SY017716-5g |
Sodium (R,E)-2-[1-[[1-[3-[2-(7-Chloro-2-quinolinyl)vinyl]phenyl]-3-[2-(2-hydroxy-2-propanyl)phenyl]propylthio]methyl]cyclopropyl]acetate |
151767-02-1 | ≥95% | 5g |
¥1091.00 | 2025-04-18 | |
| TRC | M568000-10mg |
Montelukast Sodium Salt |
151767-02-1 | 10mg |
$ 58.00 | 2023-09-06 | ||
| TRC | M568000-25mg |
Montelukast Sodium Salt |
151767-02-1 | 25mg |
$74.00 | 2023-05-17 | ||
| TRC | M568000-50mg |
Montelukast Sodium Salt |
151767-02-1 | 50mg |
$ 85.00 | 2023-09-06 |
Montelukast Sodium Suppliers
Montelukast Sodium Related Literature
-
Juergen Thun,Wolfgang Milius,Bastian Wedel,Andre Ridder,Peter Moersdorf,Josef Breu CrystEngComm 2009 11 1306
-
Shoujun Zheng,Xinyi Fang,Fan Li,Qiaomei Sun,Mu Zhao,Huiping Wei,Wanyu Xu,Hui Li New J. Chem. 2022 46 22294
-
Hemant Madhusudan Gandhi,Nageswara Rao Gollapalli,Jaydeep Kumar D. Lilakar,Kirti Kumar Jain,Sandeep Mohanty Anal. Methods 2016 8 1667
-
Neela M. Bhatia,Vinod L. Gaikwad,Rohan V. Mane,Rakesh P. Dhavale,Manish S. Bhatia New J. Chem. 2018 42 4384
-
Neela M. Bhatia,Vinod L. Gaikwad,Rohan V. Mane,Rakesh P. Dhavale,Manish S. Bhatia New J. Chem. 2018 42 4384
151767-02-1 (Montelukast Sodium) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)